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Abstract
Background Hyperpolarization-activated cyclic nucleo-
tide (HCN) channels are pacemaker channels that regulate
heart rate and neuronal rhythm in spontaneously active
cardiac and neuronal cells. Interstitial cells of Cajal (ICCs)
are also spontaneously active pacemaker cells in the gas-
trointestinal tract. Here, we investigated the existence of
HCN channel and its role on pacemaker activity in colonic
ICCs.
Methods We performed whole-cell patch clamp, RT-
PCR, and Ca2?-imaging in cultured ICCs from mouse mid
colon.
Results SQ-22536 and dideoxyadenosine (adenylate
cyclase inhibitors) decreased the frequency of pacemaker
potentials, whereas both rolipram (cAMP-specific phos-
phodiesterase inhibitor) and cell-permeable 8-bromo-
cAMP increased the frequency of pacemaker potentials.
CsCl, ZD7288, zatebradine, clonidine (HCN channel
blockers), and genistein (a tyrosine kinase inhibitor)
suppressed the pacemaker activity. RT-PCR revealed
expression of HCN1 and HCN3 channels in c-kit and Ano1
positive colonic ICCs. In recordings of spontaneous intra-
cellular Ca2? [Ca2?]i oscillations, rolipram and 8-bromo-
cAMP increased [Ca2?]i oscillations, whereas SQ-22536,
CsCl, ZD7288, and genistein decreased [Ca2?]i oscilla-
tions.
Conclusions HCN channels in colonic ICCs are tonically
activated by basal cAMP production and participate in
regulation of pacemaking activity.
Keywords Hyperpolarization-activated cyclic nucleotide
channels  Interstitial cells of Cajal  Pacemaker activity 
cAMP  Colon
Introduction
Interstitial cells of Cajal (ICCs) are pacemaker cells and
play an important role in the regulation of smooth muscle
activity by producing and propagating slow waves, trans-
ducing neural input to smooth muscles, and acting as
stretch receptors in the gastrointestinal (GI) tract [1–3].
Many neurotransmitters and hormones affect the frequency
and configuration of slow waves, thus regulating GI
motility [4]. ICCs generate spontaneous pacemaker
potentials that correlate with peristaltic contractions in the
small intestine [5]. The pacemaking mechanism has been
well studied in cultured ICCs and intact mouse small
intestine [6, 7]. The coupling between IP3-gated Ca
2?
release from endoplasmic reticulum and reuptake of Ca2?
into mitochondria is linked to generation of pacemaker
activity by periodically activating Ca2?-dependent mem-
brane pacemaker ion channels [8]. Transient receptor
potential (TRP) channels or Ca2?-activated Cl- channels
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were candidates as pacemaker channels in ICCs [9–12].
Recently it was found that Ano1, which encodes Ca2?-
activated Cl- channels and was known as a selective
marker of ICCs, plays an important role in pacemaking due
to loss of slow waves by the knockout of Ano1 [13, 14].
However, Ano1 is also expressed in non-active secretory
epithelial cells [15–17] of the lung, kidney and salivary
glands. It was also reported that Ano1 acts as a regulator
for proliferation of ICCs [18].
The frequency and configuration of GI pacemaker
activity is affected by temperature and energy metabolism
[19, 20]. Moreover, slow waves were found to be sensitive
to intracellular cAMP level in the canine colon [21, 22].
Therefore, it was suggested that an intracellular metabolic
process involving Ca2? release from endoplasmic reticu-
lum that is sensitive to cAMP levels triggers the colonic
slow waves. cAMP is a second messenger and acts as an
inhibitory agent in regulating GI motility [23]. However, in
spontaneously active cardiac and neuronal cells, cAMP
mediates excitatory responses that increase heart rates and
neuronal firing rates. Hyperpolarization-activated cyclic
nucleotide (HCN) channels are pacemaker channels that
present in a variety of spontaneously active cells such as
heart and neurons and play an important role in regulation
of cell excitability [24, 25]. These channels are activated
directly by cAMP [26]. ICCs are spontaneously active
pacemaker cells and are rich in mitochondria, suggesting
that HCN channels may exist in these cells. Thus, in this
present study, we performed a series of functional and
molecular experiments to investigate whether HCN chan-
nels exist in colonic ICCs and what physiological roles
they have in the pacemaking activity of the mouse mid-
colon.
Methods
Preparation of cells and tissues
The protocols and animal care used in these experiments
were in accordance with the guiding principles approved
by the ethics committee in Chosun University and the
National Institutes of Health Guide, South Korea for the
Care and Use of Laboratory Animals. Mice had free access
to water and a standard mouse diet until the day of
experimentation. Balb/C mice (5–8 days old) of either sex
were anesthetized with ether and sacrificed by cervical
dislocation. The small intestines from 1 cm below the
pyloric ring to the cecum were removed and opened along
the mesenteric border. The colon from below cecum to
rectum were removed and mid region of the colon was
used. Colon were opened along the mesenteric border. The
luminal contents were washed away with Krebs–Ringer
bicarbonate solution. The tissues were pinned to the base of
a Sylgard dish and the mucosa was removed by sharp
dissection. Small strips of intestinal muscle or colonic
muscle were equilibrated in Ca2?-free Hank’s solution for
30 min, and the cells were dispersed with an enzyme
solution containing 1.3 mg/ml collagenase (Worthington
Biochemical Co., Lakewood, NJ, USA), 2 mg/ml bovine
serum albumin (Sigma, St. Louis, MO, USA), 2 mg/ml
trypsin inhibitor (Sigma), and 0.27 mg/ml ATP. Cells were
plated onto sterile glass coverslips coated with poly L-
lysine (2.5 lg/ml, Sigma) in 35 mm culture dishes. The
cells were then cultured at 37 C in a 95 % O2/5 % CO2
incubator in smooth muscle growth medium (SMGM,
Clonetics Corp., San Diego, CA, USA), supplemented with
1 % antibiotics/antimycotics (Gibco, Grand Island, NY,
USA) and 5 ng/ml murine stem cell factor (SCF, Sigma).
Patch-clamp experiments
The patch-clamp technique was tested using ICCs that
showed the network-like structures in culture (2–3 days).
The whole-cell configuration of the patch clamp technique
was used to record membrane potentials (current clamp).
Membrane potentials were amplified by Axopatch 200B
(Axon Instruments, Foster, CA, USA). Command pulse
was applied using an IBM-compatible personal computer
and pClamp software (version 9.2, Axon Instruments). The
data were filtered at 5 kHz and displayed on an oscillo-
scope and a computer monitor. Results were analyzed
using Clampfit program (Axon Instruments) and GraphPad
Prism software (version 2.01, GraphPad Software Inc., San
Diego, CA, USA). All experiments pertaining to patch
clamp were performed at 30 C.
Collection of ICCs and RT-PCR
Cells which had the morphology of ICCs, triangular or
spindle shapes with multiple branches, were collected
(about 2–5 cells) by applying negative pressure to a cell in
contact with a recording pipette, lifting the cell out of the
bath, and immediately expelling the cell from the pipette
by applying positive pressure into a 1.5 ml tube which
contained Phosphate-buffered saline. The cells were spun
down at 3000 rpm for 5 min and then lysis buffer was
added. Total RNA was isolated using TRIzol reagent
according to the manufacturer specifications (Invitrogen,
CA, USA). cDNAs were produced from the total RNA
using Superscript One-Step RT-PCR with Platinum Taq
(Invitrogen). The primers used were as follows: HCN1
(Accession number NM_010408), forward 50-GCCATGC
TGAGCAAGCTGAGATTT-30, reverse 50-TCCGATCG
AGTCGGTCAATAGCAA-30 (with a product size of
325 bp); HCN2 (Accession number NM_008226), forward
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50-CACAGCCATGCTGACAAAGCTCAA-30, reverse 50-
ATCTAGCCGGTCAATAGCCACAGT-30 (with a product
size of 325 bp); HCN3 (Accession number NM_008227),
forward 50-TCTGCAGTTTCTGGTCCCTATGCT-30,
reverse 50-ACTGCTCCACCTGCTTGTACTTCT-30 (with
a product size of 308 bp); HCN4 (Accession number
NM_001081192), forward 50-ATCGTGGTGGAGGACAA
CACAGAAT-30, reverse 50-GACACAGCAGAAGCATC
ATGCCAA-30 (with a product size of 337 bp); c-Kit
(Accession number Y00864), forward 50-GAGCCTTCCT
GTGACAGTTCAAAT-30, reverse 50-TCTATTCTTGCG
GATCTCCTCTTG-30 (with a product size of 101 bp);
Ano1 (Accession number NM_178642), forward 50-AGGC
CAAGTACAGCATGGGTATCA-30, reverse 50-AGTACA
GGCCAACCTTCTCACCAA-30 (with a product size of
213 bp); Myosin (Accession number NM_013607.2),
forward 50-GAGAAAGGAAACACCAAGGTCAAGC-30,
reverse 50-AACAAATGAAGCCTCGTTTCCTCTC-30 (with
a product size of 233 bp); and PGP9.5 (Accession number
NM_011670), forward 50-GCCAACAACCAAGACAAGC
TGGAA-30, reverse 50-GCCGTCCACGTTGTTGAACAG
AAT-30 (with a product size of 213 bp). The thermal cycler
was programmed such that cDNA synthesis was fol-
lowed immediately by PCR amplification. The cDNA
synthesis was carried out at 45 C for 30 min for the
reverse transcription reaction followed by 94 C for
5 min for the denaturation of the cDNA hybrid. The
three-step cycling process was carried out as follows for
38 cycles: 94 C for 30 s for denaturation, 60 C for
30 s for annealing, and 72 C for 30 s for the extension.
The PCR products were visualized using 2 % agarose
gel electrophoresis followed by ethidium bromide
staining.
Measurement of intracellular Ca2? concentration
Fluo-3/AM, which was initially dissolved in dimethyl
sulfoxide and stored at -20 C, was used for monitoring
changes in the intracellular Ca2? ([Ca2?]i) concentration.
Cultured ICCs on coverslips (25 mm) were rinsed twice
using bath solution (recipe below), followed by incubation
in bath solution containing 1 lM fluo-3/AM with 5 % CO2
at 37 C for 5 min, and were then rinsed 2 more times with
bath solution. They were then mounted on a perfusion
chamber and scanned every 0.4 s using a Nikon Eclipse
TE200 inverted microscope equipped with a Perkin-Elmer
Ultraview confocal scanner and a Hamamatsu Orca ER
12-bit CCD camera (2009). Fluorescence excitation
occurred at a wavelength of 488 nm and the emitted light
was observed at 515 nm. The temperature of the perfusion
chamber containing the cultured ICC was maintained at
30 C during the scanning of Ca2? imaging. Variations of
[Ca2?]i fluorescence emission intensity were expressed as
F1/F0 where F0 is the intensity of the first imaging.
Reagents
The cells were bathed in bath solution containing (mM):
KCl 5, NaCl 135, CaCl2 2, glucose 10, MgCl2 1.2 and
HEPES 10 and was adjusted to pH 7.4 with Tris. The
pipette solution contained 140 mM KCl, 5 mM MgCl2,
2.7 mM K2ATP, 0.1 mM Na2GTP, 2.5 mM creatine
phosphate disodium, 5 mM HEPES, and 0.1 mM EGTA,
adjusted to pH 7.2 with Tris. The drugs used were: tetro-
dotoxin, nicardipine, SQ-22536, dideoxyadenosine, roli-
pram, 8-bromo-cAMP, CsCl, ZD7288, zatebradine,
clonidine, genistein, L-cis-diltiazem, KT-5720, and
8-pCPT-20-O-Me-cAMP. ZD7288 and zatebradine were
purchased from Calbiochem (San Diego, CA, USA) and
the other compounds were purchased from Sigma.
Statistical analysis
Data are expressed as the means ± standard errors. Dif-
ferences in the data were evaluated by the Student’s t test.
A p value \0.05 was considered to indicate a statistically
significant difference. The n values reported in the text
refer to the number of cells used in the patch clamp
experiments.
Results
Involvement of cAMP production in generating
pacemaker potentials in ICCs
The patch clamp technique was tested with ICCs that had
network-like structures in culture (2–3 days). In the current
clamp mode, the ICCs generated pacemaker potentials
(Fig. 1a). Under control conditions in the current clamp
mode, the resting membrane potential, frequency and
amplitude were -58.7 ± 2.5 mV, 7.9 ± 2.6 cycles/5 min,
and 41.4 ± 7.9 mV, respectively (n = 23; Fig. 1a, d, e).
To evaluate whether voltage-dependent Na? and Ca2?
channels were involved in generating pacemaker poten-
tials, we first treated with tetrodotoxin (TTX, 1 lM;
n = 10) and nicardipine (1 lM; n = 9). We found that the
resting membrane potential, frequency, and amplitude of
pacemaker potentials were not changed by TTX and ni-
cardipine (Fig. 1b, c), indicating that voltage-dependent
Na? and L-type Ca2? channels were not involved in gen-
erating pacemaker potentials. Since HCN channels were
activated directly by cAMP, we next examined the
involvement of cAMP using SQ-22536 (100 lM; n = 6),
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dideoxyadenosine (100 lM; n = 6) (both adenylate
cyclase inhibitors), rolipram (a cAMP-specific phosphodi-
esterase inhibitor, 100 lM; n = 7), and cell-permeable
8-bromo-cAMP (100 lM; n = 8). Both SQ-22536 and
dideoxyadenosine decreased the frequency of pacemaker
potentials and hyperpolarized the membrane. In contrast,
rolipram and cell-permeable 8-bromo-cAMP increased the
frequency of pacemaker potentials and depolarized the
membrane (Fig. 2a–d). The values of the frequency
induced by above drugs were significantly different from
the control values (Fig. 2f). However, the values of the
resting membrane potential induced by these drugs were not
significantly different from control values even though they
changed membrane potentials (Fig. 2e). These results suggest
that basal intracellular cAMP plays an important role in reg-
ulating the pacemaker frequency in colonic ICCs.
The cellular action of cAMP is mediated mainly by
protein kinase A (PKA) or cAMP-regulated guanine
nucleotide exchange factor (Epac) [27]. Thus, to assess
whether basal cAMP action was mediated by either PKA or
Epac, we examined the effect of KT-5720 (a PKA inhibi-
tor, 10 lM; n = 7) or 8-pCPT-20-O-Me-cAMP (an Epac
agonist, 100 lM; n = 7), and found that both KT-5720 and
Epac agonist had no effects on pacemaker activity (Fig. 3a,
b). Since cyclic nucleotide gated (CNG) channel is another
downstream target of cAMP [28], we treated with L-cis-
diltiazem, a CNG channel blocker (10 lM; n = 7). We
found that L-cis-diltiazem also had no effect on pacemaker
activity (Fig. 3c). The values of the resting membrane
potential and frequency induced by the above drugs were
not significantly different from control values (Fig. 3d, e).
These results suggest that cAMP-dependent regulation of
pacemaker frequency was not mediated by PKA, Epac or
CNG channels.
The effects of HCN channel blockers on pacemaker
activity in cultured colonic ICCs
To evaluate whether the cAMP-dependent regulation of
pacemaker activity was mediated through HCN channels,
we treated ICCs with HCN channel blockers such as CsCl
(5 mM; n = 6), ZD7288 (10 lM; n = 8), zatebradine
(10 lM; n = 8), and clonidine (100 lM; n = 6) [29]. In
addition, there is a report that Src tyrosine kinase inhibitor,
genistein, modulates HCN channels [30], we also treated
genistein (10 lM; n = 5) to pacemaker potential generat-
ing colonic ICCs. We found that CsCl, ZD7288, zatebra-
dine, clonidine, and genistein all decreased the frequency
of pacemaker potentials (Fig. 4a–e). The responses to the
above drugs on the pacemaker potentials in ICCs are
summarized in Fig. 4f and g. The values of the frequency
induced by the above drugs were significantly different
from control values. These results suggest that the cAMP-
dependent regulation of pacemaker activity may be medi-
ated through HCN channels.
The expression of HCN1 and HCN3 channels
in colonic ICCs
To support the above functional data, we performed RT-PCR
to detect expression of HCN channels. There are four subtypes
of the HCN channels: HCN1–HCN4. In this study, we used
mouse heart and HEK-293 cells as positive and negative
controls for HCN channels (n = 4; Fig. 5a). RT-PCR analysis
revealed the mRNA transcripts for all four HCN channel
subtypes in whole mount cultured colonic cells (n = 12;
Fig. 5b). However, the mRNA transcripts for only HCN1 and
HCN3 channel were detected in cultured c-kit and Ano1
positive isolated ICCs (n = 14; Fig. 5c).
Fig. 1 Effects of voltage-
dependent Na? or L-type Ca2?
channel blocker on the
spontaneous pacemaker
potentials in cultured ICCs of
the mouse colon. Control (a),
tetrodotoxin (TTX; 1 lM)
(b) and nicardipine (1 lM)
(c) had no effect on the
spontaneous pacemaker
potentials in current clamping
mode. The effects of TTX and
nicardipine on pacemaker
potentials are summarized in
d and e. Bars represent
mean ± SE values (p \ 0.05)
con control, TTX tetrodotoxin
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The effects of cAMP-related drugs and HCN channel
blockers on [Ca2?]i oscillations of ICCs
In cultured intestinal ICCs, the activity of pacemaker
channels was found to be closely coupled with spontaneous
[Ca2?]i oscillations [31]. Thus, to evaluate whether HCN
channels activation is coupled with spontaneous [Ca2?]i
oscillations, we measured spontaneous [Ca2?]i oscillations
in cultured colonic ICCs that are connected with cell
cluster and treated with 8-bromo-cAMP (100 lM; n = 6),
rolipram (100 lM; n = 6), SQ-22536 (100 lM; n = 6),
CsCl (5 mM; n = 6), ZD7288 (10 lM; n = 6), and geni-
stein (10 lM; n = 4). ICCs were loaded with fluo3-AM
and spontaneous [Ca2?]i oscillations were observed in a
time series. The frequency of [Ca2?]i oscillations was
7.3 ± 1.6 cycles/5 min in the control (n = 34). Both
Fig. 2 Effects of cAMP-
related drugs on the
spontaneous pacemaker
potentials in cultured ICCs of
the mouse colon. SQ-22536
(100 lM) (a) and
dideoxyadenosine (100 lM)




(100 lM) (c), a cAMP specific
PDE 4 inhibitor, and cell
permeable 8-bromo-cAMP
(100 lM) (d) increased the
frequency of pacemaker
potentials. The effects of these
drugs on pacemaker potentials
are summarized in e and f. Bars
represent mean ± SE values
(p \ 0.05) con control, ddA
didoxyadenosine
Fig. 3 Effects of protein
kinase A (PKA) inhibitor,
cAMP-regulated guanine
nucleotide exchange factor
(Epac) agonist, and cyclic
nucleotide gated (CNG) channel
blocker on the spontaneous
pacemaker potentials in cultured
ICCs of the mouse colon. KT-
5720, a PKA inhibitor (10 lM)
(a), 8-pCPT-20-O-Me-cAMP, an
Epac agonist (10 lM) (b), and
L-cis-diltiazem, a CNG channel
blocker (10 lM) (c) had no
effect on the spontaneous
pacemaker potentials. The
effects of KT-5720, 8-pCPT-20-
O-Me-cAMP and L-cis-
diltiazem on pacemaker
potentials are summarized in
d and e. Bars represent
mean ± SE values (p \ 0.05)
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8-bromo-cAMP and rolipram increase spontaneous [Ca2?]i
oscillations (Fig. 6a, b). In contrast, SQ-22536, CsCl,
ZD7288, and genistein all decreased spontaneous [Ca2?]i
oscillations (Fig. 6c–f). The values of the frequency
induced by the above drugs were significantly different
from control values. These results suggested that the basal
activation of HCN channels may be coupled with sponta-
neous [Ca2?]i oscillations (Fig. 6g).
HCN channels were not involved in the generation
of pacemaker potentials in intestinal ICCs
To evaluate whether HCN channels also involve in intes-
tinal pacemaking, we treated intestinal ICCs with SQ-
22536 (100 lM; n = 5), rolipram (100 lM; n = 5),
8-bromo-cAMP (100 lM; n = 9), CsCl (5 mM; n = 6),
ZD7288 (10 lM; n = 5), zatebradine (10 lM; n = 5),
clonidine (100 lM; n = 5), and genistein (10 lM; n = 6)
and performed RT-PCR. We found that all the drugs had no
effect on pacemaker potentials of intestinal ICCs (Fig. 7a–
h). In RT-PCR analysis, the mRNA transcripts for four
HCN channel subtypes were detected in whole-mount
cultured intestinal cells (n = 6; Fig. 8a). However, none of
the HCN channel subtypes were expressed in cultured c-kit
and Ano1 positive intestinal ICCs (n = 10; Fig. 8b).
Discussion
In the present study, our data suggest that tonically acti-
vated HCN channels participate in regulating pacemaker
activity in colonic ICCs. The major findings of this study
are that basal intracellular cAMP production maintains the
Fig. 4 Effects of
hyperpolarization-activated
cyclic nucleotide (HCN)
channel blockers on the
spontaneous pacemaker
potentials in cultured ICCs of
the mouse colon. CsCl (5 mM)
(a), ZD7288 (10 lM) (b),
zatebradine (10 lM) (c),
clonidine (100 lM) (d), and
genistein (10 lM) (e). All traces
showed the reduced frequency
of pacemaker potentials. The
effects of these drugs on
pacemaker potentials are
summarized in f and g. Bars
represent mean ± SE values
(p \ 0.05)
Fig. 5 RT-PCR detection and expression of hyperpolarization-
activated cyclic nucleotide (HCN) channels protein in cultured ICCs
of mouse mid colon. Mouse heart and HEK-293 cells were used as
positive and negative controls (a). Four HCN channel subtypes
(HCN1–HCN4) were amplified in whole mounted cultured cells from
mouse colon (b). However, only the HCN1 and HCN3 channel
subtypes were amplified in c-kit and Ano1 positive cultured colonic
ICCs (c)
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resting pacemaker activity in colonic ICCs and that HCN
channel blockers inhibited the pacemaker activity and
decrease intracellular Ca2? oscillations. In addition, we
observed that the expression of HCN channels by RT-PCR
in colonic ICCs. To our knowledge, the findings of this
study are the first to suggest that HCN channels may be
present in colonic ICCs and regulate pacemaker activity.
HCN channels are a family of non-selective cationic
channels that conduct Na? and K?. These channels are
comprised of four subtypes (HCN1–HCN4) and each
subtype has six transmembrane domains containing intra-
cellular N- and C-terminus. HCN channels are activated by
hyperpolarization of the membrane and by direct binding
of intracellular cAMP to a cyclic nucleotide-binding
domain (CNBD) on the C-terminus [32]. Neurotransmitters
can influence firing rates of active spontaneous cells by
either increasing or decreasing cAMP levels through HCN
channels. Cardiac sinoatrial cells have If (funny)-currents
that regulate heart rate mediated by HCN channels. Sym-
pathetic b-adrenoceptor stimulation increases intracellular






oscillations in cultured colonic
ICCs. Cell permeable 8-bromo-
cAMP (100 lM) (a) and
rolipram (100 lM)
(b) increased the frequency of
intracellular Ca2? oscillations.
In contrast SQ-22536 (100 lM)
(c), dideoxyadenosine (100 lM)
(d), ZD7288 (10 lM) (e) and
genistein (10 lM) (f) decreased
the frequency of intracellular
Ca2? oscillations




channel blockers on the
spontaneous pacemaker
potentials in cultured ICCs from
mouse small intestine. SQ-
22536 (100 lM) (a), rolipram
(100 lM) (b), 8-bromo-cAMP
(100 lM) (c), CsCl (5 mM) (d),
ZD7288 (10 lM) (e),
zatebradine (10 lM) (f),
clonidine (100 lM) (g), and
genistein (10 lM) (h) all had no
effect on pacemaker potentials
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cAMP level and leads to increased f-channel activity fol-
lowed by increased heart rate. Whereas parasympathetic
muscarinic receptor stimulation decreases intracellular
cAMP level and leads to a decrease in f-channel activity
followed by decreased heart rate [33].
We thought the possibilities that HCN channels can
exist in ICCs because ICCs are also active pacemaker cells.
Thus, we were curious whether the pacemaker activity in
colonic ICCs is regulated by intracellular cAMP. The
intracellular cAMP level depends on the activity of two
groups of enzyme: the adenylate cyclase that produces
cAMP and the phosphodiesterase (PDE) that hydrolyzes
cAMP [34, 35]. In this study, SQ-22536 and dideoxy-
adenosine, both adenylate cyclase inhibitors, decreased the
frequency of pacemaker potentials in colonic ICCs. In
contrast, rolipram, a specific cAMP-dependent PDE 4
inhibitor, and a cell-permeable 8-bromo-cAMP both
increased the frequency of pacemaker potentials. These
results strongly suggest that basal intracellular cAMP
production maintains the resting pacemaker frequency in
colonic ICCs. cAMP is a key second messenger that
transmits information to many different effector proteins
within the cell. The cellular action of cAMP is mediated by
PKA or Epac. However, KT-5720, a PKA inhibitor, or
8-pCPT-20-O-Me-cAMP, an Epac agonist had no effects on
pacemaker activity, indicating that the regulatory effect of
cAMP on pacemaker frequency in colonic ICCs is direct
rather than being mediated by protein phosphorylation.
This finding suggests that another pathway of cAMP-
mediated regulation of pacemaker activity exist in colonic
ICCs. CNG and HCN channels are other downstream target
proteins of cAMP [36]. However, L-cis-diltiazem, a CNG
channel blocker, did not change the pacemaker potentials.
Thus, we postulated that HCN channels may be a target
protein of cAMP for regulation of pacemaker activity in
colonic ICCs. To support this hypothesis, we performed
pharmacological studies. Pharmacologically, Cs?, ZD7288
and zatebradine are HCN channel blockers that are com-
monly used in identification of HCN channels in various
cells [37]. It has also been reported that clonidine, a a2-
adrenoceptor agonist, directly blocks the HCN channels
activity in cardiac sinoatrial cells [38]. Regulation of HCN
channel by tyrosine kinases of the Src family has been also
reported in heart and neuron [39]. In this study, HCN
channel blockers and the tyrosine kinase inhibitor, geni-
stein suppressed pacemaker frequency in colonic ICCs.
These above results suggest that HCN channels are under
tonically activated by basal cAMP in colonic ICCs. The
similar results have been reported in spontaneous firing
GH3 cells where basal cAMP tonically activates HCN
channels [40].
To confirm and support the functional data, we per-
formed RT-PCR in colonic ICCs in cultured cells. The
distribution of HCN channel subunits was both regional-
and species-dependent. In the central nervous system,
HCN1 channel was found to be expressed mainly in the
photoreceptors, neocortex, and cerebellar cortex. HCN2
channel was expressed in nearly all brain tissues. HCN3
channel was found in the olfactory bulb and HCN4 channel
was found in the thalamus and olfactory bulb. In the heart,
all four HCN channel subunits are detected [41]. In sin-
oatrial nodes, the HCN4 channel is the major subunit in all
species and the remaining small fraction of these channels
is species dependent. HCN1 channel is dominant in rabbit,
whereas the HCN2 channel is dominant in mouse and
human [42]. In the GI tract of mice, enteric neurons
expressed HCN1, HCN2, and HCN4 channels but not
HCN3 channels [43]. Recently, Yang et al. [44] investi-
gated the role HCN2 channels on spontaneous rhythmic
activity of GI tract in mice. However, immunoreactivity of
the anti-HCN2 antibody was only detected in myenteric
neurons and not in ICCs. In our study, RT-PCR analysis
revealed the presence of mRNA transcripts for all four
HCN channels subtypes in the whole mount cultured
colonic cells. However, in c-kit and Ano1 positive colonic
ICCs, only mRNA transcripts for the HCN1 channel and
HCN3 channel were expressed. Taken together these
results suggest that ICCs also have HCN channels and have
regional differences in distribution of HCN channels in
mouse.
The pacemaking mechanism in intestinal ICCs is related
to IP3-dependent intracellular Ca
2? oscillations that are
coupled with the periodic activation of pacemaker chan-
nels. In this study, intracellular Ca2? oscillations are
increased by rolipram or 8-bromo-cAMP and decreased by
SQ-22536 or dideoxyadenosine in colonic ICCs. In addi-
tion, HCN channel blockers suppressed spontaneous
intracellular Ca2? oscillations. This suggests the activation
Fig. 8 RT-PCR detection and expression of hyperpolarization-
activated cyclic nucleotide (HCN) channel proteins in cultured ICCs
of mouse small intestine. Four HCN channel subtypes (HCN1–
HCN4) were amplified in whole mount cultured cells from mouse
small intestine (a). In contrast, none of the subtypes of HCN channels
were detected in c-kit and Ano1 positive cultured intestinal ICCs (b)
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of HCN channels and intracellular Ca2? oscillations are
also closely coupled to generate pacemaker activity.
Finally we also performed pharmacological experiments
and RT-PCR on intestinal ICCs to compare with the results
from colonic ICCs. In contrast to colonic ICCs, all cAMP-
related drugs and HCN channel blockers had no effect on
the intestinal pacemaker frequency. HCN channels were
not detected in the intestinal ICCs by RT-PCR. These
results strongly suggest that there are regional differences
in HCN channels and that different pacemaking mecha-
nisms may exist between the small intestine and the colon.
In summary, periodically activated HCN channels by
basal intracellular cAMP production are present in colonic
ICCs and they regulate pacemaker activity. The different
regional distribution in HCN channels between the intes-
tine and colon suggest a cause for differential regulation of
GI motility. Our results suggest that HCN channel may
participate in regulation of pacemaking activity and may be
an effective therapeutic target for abnormal colonic
motility disorders. However, because our study was per-
formed in cultured cells, further studies are require to
confirm the existence of HCN channels and elucidate the
fine precise mechanisms in native tissues.
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